Q4 2026 Earnings Call February 25, 2026 5:00 PM ESTCompany ParticipantsToshiya Hari - Vice President of Investor Relations ...
Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results